Cargando…
A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein
The ongoing global health crisis caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus which leads to Coronavirus Disease 2019 (COVID-19) has impacted not only the health of people everywhere, but the economy in nations across the world. While vaccine candidates and thera...
Autores principales: | Martin, William R., Cheng, Feixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ChemRxiv
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418723/ https://www.ncbi.nlm.nih.gov/pubmed/32793875 http://dx.doi.org/10.26434/chemrxiv.12770225 |
Ejemplares similares
-
Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering
por: Ong, Edison, et al.
Publicado: (2020) -
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2
Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020) -
Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020) -
Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
por: Umitaibatin, Ramadhita, et al.
Publicado: (2023) -
Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022)